Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
883.55
850.46
645.49
500.60
556.08
532.31
474.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
883.55
850.46
645.49
500.60
556.08
532.31
474.40
Raw Material Cost
99.07
99.26
81.00
67.23
67.98
68.59
68.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
225.01
238.29
147.92
133.68
123.87
117.28
113.14
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.24
0.24
0.38
0.00
0.00
0.00
0.10
Selling and Distribution Expenses
457.79
463.89
358.39
298.60
326.57
307.06
279.57
Other Expenses
-18.74
-18.37
-9.41
-10.52
-9.10
-8.66
-9.40
Total Expenditure (Excl Depreciation)
594.71
617.99
493.64
394.28
427.45
406.37
367.38
Operating Profit (PBDIT) excl Other Income
288.8
232.5
151.8
106.30000000000001
128.6
125.9
107
Other Income
-31.10
22.83
25.11
30.29
20.65
4.07
7.18
Operating Profit (PBDIT)
269.25
265.55
194.84
150.00
162.65
143.00
118.63
Interest
0.24
0.24
0.38
0.00
0.00
0.00
0.10
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-0.86
Gross Profit (PBDT)
784.48
751.21
564.49
433.37
488.10
463.71
405.80
Depreciation
11.50
12.28
13.84
14.07
14.12
13.22
4.43
Profit Before Tax
257.51
253.03
180.62
135.94
148.53
129.78
113.24
Tax
34.39
28.71
20.27
18.22
18.67
17.00
16.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
219.33
219.09
154.67
114.90
129.72
112.91
96.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
219.33
219.09
154.67
114.90
129.72
112.91
96.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.35
-0.32
-0.40
-0.55
0.14
-0.13
0.31
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
218.98
218.77
154.26
114.35
129.86
112.78
96.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,248.64
1,904.84
1,688.43
1,601.99
1,569.48
463.74
350.83
Earnings per share (EPS)
1.13
1.17
0.83
0.61
0.69
0.6
0.52
Diluted Earnings per share
1.13
1.17
0.83
0.61
0.69
0.6
0.52
Operating Profit Margin (Excl OI)
32.69%
27.1%
24.15%
21.1%
23.0%
23.62%
22.56%
Gross Profit Margin
30.45%
31.2%
30.13%
29.96%
29.25%
26.86%
24.8%
PAT Margin
24.82%
25.76%
23.96%
22.95%
23.33%
21.21%
20.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 3.89% vs 31.76% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 0.09% vs 41.80% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 23.73% vs 43.02% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 0.00% vs -50.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Jiangsu Jibeier Pharmaceutical Co. Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
883.55
0
883.55
Other Operating Income
0.00
0.00
0.00
Total Operating income
883.55
0
883.55
Raw Material Cost
99.07
0
99.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
225.01
0
225.01
Power Cost
0
0
0.00
Manufacturing Expenses
0.24
0
0.24
Selling and Distribution Expenses
457.79
0
457.79
Other Expenses
-18.74
0.00
-18.74
Total Expenditure (Excl Depreciation)
594.71
0
594.71
Operating Profit (PBDIT) excl Other Income
288.85
0.00
288.85
Other Income
-31.10
0
-31.10
Operating Profit (PBDIT)
269.25
0
269.25
Interest
0.24
0
0.24
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
784.48
0
784.48
Depreciation
11.50
0
11.50
Profit Before Tax
257.51
0
257.51
Tax
34.39
0
34.39
Provisions and contingencies
0
0
0.00
Profit After Tax
219.33
0
219.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
219.33
0
219.33
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.35
0
-0.35
Other related items
0.00
0.00
0.00
Consolidated Net Profit
218.98
0
218.98
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,248.64
0
2,248.64
Earnings per share (EPS)
1.13
0
1.13
Diluted Earnings per share
1.13
0
1.13
Operating Profit Margin (Excl OI)
32.69%
0%
0.00
32.69%
Gross Profit Margin
30.45%
0%
0.00
30.45%
PAT Margin
24.82%
0%
0.00
24.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 88.36 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 3.89% vs 31.76% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 21.90 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 0.09% vs 41.80% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.03 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 23.73% vs 43.02% in Dec 2023
Annual - Interest
Interest 0.02 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 0.00% vs -50.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.69%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






